Vigabatrin-induced modification of Ki-67 expression in gingival epithelium: immunohistochemical study of a short series

J Periodontal Res. 2004 Feb;39(1):66-71. doi: 10.1111/j.1600-0765.2004.00711.x.

Abstract

Objective: To study the expression and role in vigabatrin (VGB)-induced gingival enlargement of Ki-67 antigen and p27KIP1, p21WAF1, and p53, proteins that activate or inhibit cell-cycle progression.

Materials and methods: Six patients treated with VGB for partial epileptic seizures refractory to classic anticonvulsant treatment were studied. Gingival biopsies were taken from four of these patients for immunohistochemical studies; 10 control biopsies from individuals with healthy gingiva and 10 from patients with periodontal disease were also evaluated.

Results: Four of the six patients presented some degree of gingival enlargement (mild or moderate). Nuclear expression of Ki-67 was elevated (mean of 894 positive cells/mm2 in VGB-induced gingival enlargement vs. 391 cells/mm2 in controls with healthy gingiva and 425 cells/mm2 in controls with periodontal disease) (p < 0.01, analysis of variance: anova), and nuclear expression of cyclin-dependent kinase (cdk) inhibitors p27KIP1 and p21WAF1 was reduced. The patients with gingival enlargement presented inflammatory infiltrate in lamina propria, mainly composed of T lymphocytes (CD3+) and plasma cells (CD38+), which was even more intense than in the biopsies of patients with periodontal disease.

Conclusion: The overexpression of antigen Ki-67 and slight underexpression of cdk-inhibitors p27KIP1 and p21WAF1 suggest that VGB induced an increase in cell proliferation and contributed, together with concomitant periodontal disease, to the gingival enlargement.

MeSH terms

  • Adolescent
  • Adult
  • Analysis of Variance
  • Anticonvulsants / adverse effects*
  • Cell Cycle Proteins / drug effects
  • Cell Division / drug effects
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclin-Dependent Kinase Inhibitor p27
  • Cyclin-Dependent Kinases / antagonists & inhibitors
  • Cyclins / drug effects
  • Enzyme Inhibitors / analysis
  • Gingiva / drug effects*
  • Gingiva / pathology
  • Gingival Overgrowth / chemically induced*
  • Gingival Overgrowth / pathology
  • Humans
  • Immunohistochemistry
  • Ki-67 Antigen / drug effects*
  • Middle Aged
  • Periodontal Diseases / metabolism
  • Periodontal Diseases / pathology
  • Plasma Cells / pathology
  • Statistics, Nonparametric
  • T-Lymphocytes / pathology
  • Tumor Suppressor Protein p53 / drug effects
  • Tumor Suppressor Proteins / drug effects
  • Vigabatrin / adverse effects*

Substances

  • Anticonvulsants
  • CDKN1A protein, human
  • Cell Cycle Proteins
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Enzyme Inhibitors
  • Ki-67 Antigen
  • Tumor Suppressor Protein p53
  • Tumor Suppressor Proteins
  • Cyclin-Dependent Kinase Inhibitor p27
  • Cyclin-Dependent Kinases
  • Vigabatrin